By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its fourth-quarter revenues increased 27 percent, driven by sales of its Oncotype DX breast cancer test.
Registering provides access to this and other free content.
Already have an account?Login Now.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.